This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ThermoGenesis Announces Sale Of Thermoline Product Line To Helmer Scientific

RANCHO CORDOVA, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, today said it has sold its ThermoLine plasma freezer and thawer product line to Helmer Scientific for an undisclosed sum of cash. ThermoGenesis received the payment during the quarter ended December 31, 2012.

"As was the case with our divestiture of the CryoSeal product line in mid-2012, this transaction is part of our long-term strategy to focus on our core business of developing enabling technologies for the stem cell regenerative medicine market," said Matthew Plavan, Chief Executive Officer of ThermoGenesis.

"The proceeds from this transaction will be used to fund market development programs for our cord blood and bone marrow stem cell processing and storage offerings. In addition, this divestiture will reduce some operating costs and free up internal resources that were previously used to provide customer support and service for ThermoLine customers," he added.

Helmer Scientific is a world leader in providing specialized scientific products that aid customers in their efforts to improve and save lives. Based in Noblesville, IN, Helmer provides solutions for storage and processing in the blood bank and laboratory. The acquisition is part of Helmer's growth strategy and a continuing commitment to providing high quality products to the medical and blood bank community.

Bruce King, President of Helmer Scientific said of the acquisition; "This line acquisition is focused on providing a solution to our customers who have voiced a need for a reliable rapid plasma freezing system. Helmer Scientific's long-standing service orientation and commitment to world-wide customer relationships, combined with our technical expertise in blood storage and processing equipment, uniquely position Helmer to support ThermoGenesis' longtime customers with a service and support infrastructure for both their freezing and thawing devices."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs